Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T08:50:23.113Z Has data issue: false hasContentIssue false

Reduced suicidality with paroxetine

Published online by Cambridge University Press:  16 April 2020

JJ López-Ibor Jr*
Affiliation:
San Carlos Hospital, Complutense University, Madrid, Spain
*
*Address for correspondence: JJ López-Ibor Jr, Nueva Zelanda 44, E-28035 Madrid, Spain
Get access

Summary

Depression is commonly associated with suicidal thoughts and behaviour. The effect of the antidepressant, paroxetine, on suicidality in depressed patients has been assessed by retrospective analysis of the worldwide database of short-term clinical trials. Data were analysed on 2963 patients treated with paroxetine. 554 placebo patients, and 1151 patients treated with an active control. The results clearly demonstrate the beneficial effect of antidepressant therapy on suicidal ideation. Paroxetine was not associated with the emergence of suicidality, which appears to be a feature of depressive disorder unrelated to antidepressant therapy.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Submit a response

Comments

No Comments have been published for this article.